Timothy G. Ferris, MD, has been named chairman and CEO of the MGPO, effective Aug. 1. Ferris served as senior vice president for Population Health Management for the MGH/MGPO and was the former medical director for the MGPO. He also was the senior vice president for Population Health Management at Partners HealthCare.
“Being a physician at MGH means working every day among the smartest, most dedicated and most compassionate people on the planet,” says Ferris. “It is a daily reminder of how much we still have to learn. I am deeply honored to be trusted with this responsibility and look forward to facing the challenges and opportunities ahead with such a terrific team.”
Ferris’ clinical activity and numerous administrative positions have made him a well-known presence throughout the MGH and MGPO – including serving as MGPO medical director from 2007 to 2014. He has spent his entire career at this hospital, beginning with his residency in 1992, training in both internal medicine and pediatrics. He continues today as an active primary care physician in Internal Medicine Associates. His clinical interest involves caring for medically complex patients, and his practice includes making home visits to the elderly.
Since 2012, Ferris has led the design and implementation of system wide care delivery changes to respond to the changing health care environment, enhancing care delivery, increasing access to care, and reducing the health care cost burden. He has successfully turned new laws, regulations and payment policies into opportunities to provide better care for patients.
Beyond his work at the MGH and Partners, Ferris has played multiple roles at the national level, including chairing the steering committee of the National Quality Forum and working as a member of the Secretary of Health and Human Services independent advisory council on physician payment policy. Ferris was integral to the MGH/MGPO’s application for and selection as the site of a six-year Medicare demonstration project examining how to redesign care to improve quality and decrease costs for Medicare beneficiaries. That highly successful project received national attention and has become the model for similar programs both in the United States and abroad.
Ferris succeeds Thomas J. Lynch, Jr., MD, who stepped down from the MGPO role in March to assume the position of chief scientific officer at Bristol-Myers Squibb.
This article was originally published in the 08/18/17 Hotline issue.